
Pharma Solutions
DSM secures active China Drug Master File for pyridoxine hydrochloride
25 May 2022 | 4 min
DSM is the global leader in the production of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) derived from either sustainable marine sources or microbial fermentation. We have a strong legacy of trust in the development and production of high-quality lipid products and we continue to innovate in the development and commercialization of new molecules, including arachadonic acid (ARA), docosapentaenoic acid (DPA), and others.
The Omega-3 fatty acids EPA and DHA have important roles in human health. Experts agree that EPA and DHA are a safe and effective option for reducing plasma triglycerides, and that EPA in particular is important for cardiovascular disease risk management.
In addition to their recognized roles in cardiovascular disease risk management, omega-3 fatty acids are under investigation as potential therapeutic candidates for a variety of health conditions, ranging from stroke, traumatic brain injury, even as a treatment for chemotherapy-related complications.
We are not just limited to EPA and DHA. DSM has the unique capability to produce a variety of lipid products from marine oils and algal fermentation to meet your custom specification. We want to work with you to get your product into the hands of patients around the world.
Contact us to find out more about how we can help you bring your lipid-based APIs to the market.
DSM has the ability to produce our lipid products to meet the potency and purity that your custom specification demands from either marine or fermentation-based sources.
Our state-of-the-art production facilities offer ICH Q7 compliant quality production, and are FDA, FSSC, and CFIA audited. In addition, DSM has a dedicated group of experts working to monitor marine oil contaminants, and our world-class analytical team has advanced test method development capabilities to help us stay ahead of an ever-changing environment.
With the world’s largest and longest operating capacity to produce both marine and fermentative based lipid products DSM has been able to offer stable and secure supply for over 25 years.
25 May 2022 | 4 min
16 May 2022 | 6 min
21 Jan 2022 | 4 min
06 Dec 2021 | 4 min
03 Nov 2021 | 4 min
22 Jul 2021 | 3 min
26 May 2021 | 3 min
07 Apr 2021 | 4 min
17 Feb 2021 | 4 min
14 Dec 2020 | 4 min
29 Oct 2020 | 7 min
29 Sep 2020 | 7 min
02 Sep 2020 | 7 min
31 Jul 2020 | 8 min
18 Feb 2020 | 5 min
10 Oct 2018 | 4 min
01 May 2018 | 8 min
Request samples, place orders and view product documentation
Download the latest copy of our Solutions Catalogue
We’re more than a partner. We’re a competitive edge.
The latest in vitamin and lipid research and industry developments
Academic studies and the latest science in educational modules
Videos exploring the growing role of vitamin APIs and lipid API intermediates